An introduction from  110
our management
- Chairman’s Statement IMPACT REPORT 2020
- Letter from the CEO
01 Annex I
Chiesi at a Glance
02
As a Benefit Corporation we are legally required to publish an annual Impact 
Positive Impacts  s
e
and Challenges Report containing the activities we put in place and the objectives we set up to  ex
n
- Products and Patients n
pursue common benefit, in compliance with the Italian Law No. 208 of 28-12-2015, 
- Processes A
- Global Value Chain Paragraphs 376-384.
- Corporate Citizenship
03
Chiesi’s contribution 
Chairman’s Statement  04
to the UN Sustainable 
Development Goals
Introduction 08
04
Annexes
- Impact Report We ACT Sustainability Manifesto 13
- Data, Methodology 
   and GRI Content Index
The specific purposes of Common Benefit of Chiesi  113
Farmaceutici 
Specific purpose of common benefit (I): Commitment to continuous  114
and sustainable innovation of processes and all business practices 
in order to minimise negative impacts and amplify positive impacts 
on people, the biosphere and the territory.       
 
Specific purpose of common benefit (II): Positive impact on people  116
and patients, with the aim of improving their health, well-being and 
quality of life.
Specific purpose of common benefit (III): Contribution to the  118
development of the local communities in which the Company operates
Specific purpose of common benefit (IV): Promotion of a conscious  120
and sustainable way of conducting business, also through 
collaborative dialogue with stakeholders
General Purpose of Common Benefit and Impact Assessment 121
Final remarks 124
Appendix: What is a Benefit Corporation and what is a B Corp 124